TISCI, GIADA
 Distribuzione geografica
Continente #
AS - Asia 76
NA - Nord America 71
EU - Europa 66
SA - Sud America 17
Totale 230
Nazione #
US - Stati Uniti d'America 67
IT - Italia 32
SG - Singapore 25
CN - Cina 18
BR - Brasile 15
VN - Vietnam 15
JP - Giappone 8
FI - Finlandia 6
HK - Hong Kong 6
NL - Olanda 6
DE - Germania 5
FR - Francia 4
IE - Irlanda 3
GB - Regno Unito 2
TR - Turchia 2
UA - Ucraina 2
AR - Argentina 1
AT - Austria 1
AZ - Azerbaigian 1
CA - Canada 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
HR - Croazia 1
ID - Indonesia 1
JM - Giamaica 1
PL - Polonia 1
RS - Serbia 1
RU - Federazione Russa 1
SV - El Salvador 1
Totale 230
Città #
Rome 24
Singapore 13
Tokyo 7
Hanoi 6
Hong Kong 6
Lappeenranta 6
Ashburn 5
Frankfurt am Main 5
Ho Chi Minh City 5
Los Angeles 5
Amsterdam 4
Lauterbourg 4
San Jose 4
Beijing 3
Buffalo 3
Council Bluffs 3
Da Nang 3
Dallas 3
Dublin 3
Memphis 3
Kyiv 2
Noblesville 2
São Paulo 2
Alexandria 1
Alfenas 1
Baku 1
Belgrade 1
Bexley 1
Brooklyn 1
Caetité 1
Campos dos Goytacazes 1
Canguaretama 1
Columbus 1
Cotia 1
Denpasar 1
Denver 1
Houston 1
Irituia 1
Istanbul 1
Jacareí 1
Jacksonville 1
Junction City 1
Kahramanmaraş 1
Kingston 1
Kitchener 1
Las Vegas 1
Liberia 1
Linares 1
Macarani 1
Orem 1
Orvieto 1
Pedreira 1
Porto Alegre 1
Portsmouth 1
Quilmes 1
Ribeirão Preto 1
Severomorsk 1
São José dos Pinhais 1
Takaminosato 1
Ubá 1
Vienna 1
Wroclaw 1
Zagreb 1
Zurich 1
Totale 162
Nome #
Targeted allele-specific FGFR2 knockdown via human recombinant ferritin nanoparticles for personalized treatment of Crouzon syndrome 72
The MYC-dependent lncRNA MB3 inhibits apoptosis in Group 3 Medulloblastoma by regulating the TGF-β pathway via HMGN5 58
A first-in-class non-cytotoxic nanocarrier based on a recombinant human ferritin boosts targeted therapy, chemotherapy and immunotherapy 56
Targeting MDM2 affects spastin protein levels and functions: implications for HSP treatment 43
Ferritin-based nanocarrier delivery of KRAS G12D inhibitor in pancreatic adenocarcinoma cells and patient-derived organoids: A novel approach for treatment 16
Tumor microenvironment-activated ferritin nanovector enables enhanced tumor delivery of KRASG12C inhibitors and degraders 3
Totale 248
Categoria #
all - tutte 497
article - articoli 497
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 994


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202543 0 0 0 0 0 0 0 19 3 2 8 11
2025/2026170 4 5 5 12 11 25 33 14 22 28 7 4
2026/202735 35 0 0 0 0 0 0 0 0 0 0 0
Totale 248